Annual Shareholders Equity
$90.58 M
-$19.27 M-17.55%
December 31, 2023
Summary
- As of February 7, 2025, IMRX annual stockholders equity is $90.58 million, with the most recent change of -$19.27 million (-17.55%) on December 31, 2023.
- During the last 3 years, IMRX annual shareholders equity has risen by +$113.06 million (+502.89%).
- IMRX annual shareholders equity is now -41.93% below its all-time high of $155.98 million, reached on December 31, 2021.
Performance
IMRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$57.72 M
-$8.58 M-12.95%
September 30, 2024
Summary
- As of February 7, 2025, IMRX quarterly stockholders equity is $57.72 million, with the most recent change of -$8.58 million (-12.95%) on September 30, 2024.
- Over the past year, IMRX quarterly shareholders equity has dropped by -$21.00 million (-26.68%).
- IMRX quarterly shareholders equity is now -63.54% below its all-time high of $158.29 million, reached on September 30, 2021.
Performance
IMRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
IMRX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.6% | -26.7% |
| 3 y3 years | +502.9% | -47.5% |
| 5 y5 years | +1487.4% | -47.5% |
IMRX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -41.9% | at low | -63.0% | at low |
| 5 y | 5-year | -41.9% | +502.9% | -63.5% | +264.1% |
| alltime | all time | -41.9% | +502.9% | -63.5% | +264.1% |
Immuneering Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $57.72 M(-12.9%) |
| Jun 2024 | - | $66.31 M(-15.8%) |
| Mar 2024 | - | $78.72 M(-13.1%) |
| Dec 2023 | $90.58 M(-17.5%) | $90.58 M(-12.9%) |
| Sep 2023 | - | $104.02 M(-9.6%) |
| Jun 2023 | - | $115.10 M(+17.7%) |
| Mar 2023 | - | $97.79 M(-11.0%) |
| Dec 2022 | $109.85 M | $109.85 M(-9.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $121.89 M(-8.8%) |
| Jun 2022 | - | $133.59 M(-7.3%) |
| Mar 2022 | - | $144.06 M(-7.6%) |
| Dec 2021 | $155.98 M(-793.8%) | $155.98 M(-1.5%) |
| Sep 2021 | - | $158.29 M(-549.9%) |
| Jun 2021 | - | -$35.19 M(-219.0%) |
| Mar 2021 | - | $29.57 M(-231.6%) |
| Dec 2020 | -$22.48 M(+244.4%) | -$22.48 M |
| Dec 2019 | -$6.53 M | - |
FAQ
- What is Immuneering annual stockholders equity?
- What is the all time high annual shareholders equity for Immuneering?
- What is Immuneering annual shareholders equity year-on-year change?
- What is Immuneering quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Immuneering?
- What is Immuneering quarterly shareholders equity year-on-year change?
What is Immuneering annual stockholders equity?
The current annual shareholders equity of IMRX is $90.58 M
What is the all time high annual shareholders equity for Immuneering?
Immuneering all-time high annual stockholders equity is $155.98 M
What is Immuneering annual shareholders equity year-on-year change?
Over the past year, IMRX annual stockholders equity has changed by -$19.27 M (-17.55%)
What is Immuneering quarterly stockholders equity?
The current quarterly shareholders equity of IMRX is $57.72 M
What is the all time high quarterly shareholders equity for Immuneering?
Immuneering all-time high quarterly stockholders equity is $158.29 M
What is Immuneering quarterly shareholders equity year-on-year change?
Over the past year, IMRX quarterly stockholders equity has changed by -$21.00 M (-26.68%)